Researchers at Baylor College of Medicine have uncovered a hidden brain pathway that explains how metformin, the world's most widely prescribed diabetes drug, lowers blood sugar. The team found that metformin suppresses a protein called Rap1 in the ventromedial hypothalamus, activating SF1 neurons that directly regulate blood glucose — a mechanism entirely separate from its known effects on the liver and intestines.
Remarkably, when metformin was delivered directly into the brains of diabetic mice, blood sugar dropped significantly at doses thousands of times lower than standard oral doses. Mice genetically engineered to lack Rap1 in the hypothalamus showed no improvement from low-dose metformin, confirming the protein is essential to this pathway.
The discovery, published in Science Advances, could lead to more targeted diabetes treatments and may also explain metformin's documented anti-aging effects on the brain. The drug has been in clinical use for over 60 years, yet this fundamental mechanism was previously unknown.
